Admission Date:  [**2194-8-8**]              Discharge Date:   [**2194-8-24**]  Date of Birth:  [**2109-1-20**]             Sex:   M  Service: SURGERY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 2836**] Chief Complaint: Duodenal perforation Periampullary mass  Major Surgical or Invasive Procedure: [**2194-8-8**]: Exploratory laparotomy with closure of duodenal perforation, placement of cholecystostomy tube and placement of [**Last Name (un) **] gastrostomy.
The patient was transferred in [**Hospital1 18**] for further evaluation and surgical repair.
Extr: 2+ distal pulses, no c/c/e  Pertinent Results: [**2194-8-8**] 05:30PM BLOOD WBC-20.5*# RBC-3.42* Hgb-10.8* Hct-32.0* MCV-94 MCH-31.6 MCHC-33.8 RDW-17.8* Plt Ct-310 [**2194-8-18**] 05:45AM BLOOD WBC-11.8* RBC-2.86* Hgb-9.3* Hct-26.9* MCV-94 MCH-32.4* MCHC-34.4 RDW-19.6* Plt Ct-281 [**2194-8-15**] 04:59AM BLOOD Glucose-142* UreaN-22* Creat-1.1 Na-140 K-3.3 Cl-109* HCO3-26 AnGap-8 [**2194-8-19**] 05:04AM BLOOD Glucose-131* UreaN-37* Creat-1.2 Na-137 K-4.1 Cl-106 HCO3-23 AnGap-12 [**2194-8-15**] 04:59AM BLOOD ALT-61* AST-72* AlkPhos-216* Amylase-305* TotBili-10.7* [**2194-8-15**] 04:59AM BLOOD Lipase-481* [**2194-8-15**] 04:59AM BLOOD Calcium-7.9* Phos-2.6* Mg-2.1 [**2194-8-12**] 07:15AM BLOOD calTIBC-150* Ferritn-1557* TRF-115* [**2194-8-19**] 05:04AM BLOOD ALT-64* AST-70* AlkPhos-206* Amylase-245* TotBili-8.0* [**2194-8-22**] 05:40AM BLOOD ALT-65* AST-79* AlkPhos-196* TotBili-9.8* [**2194-8-23**] 05:49AM BLOOD TotBili-8.7* .
Percutaneous transhepatic cholangiogram via left hepatic duct, demonstrating intrahepatic biliary ductal dilation, with a severe irregular stricture in the lower third of the common bile duct, compatible with known periampullary mass.
He was started on 2.5 mg Metoprolol IV with good effect and patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored.
Pulmonary: Chest xray on admission revealed bilateral atelectasis.
Repeat CXR after the patient was extubated revealed decreased atelectasis.
The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored.
Cholangiogram demonstated decreased flow into duodenum, but luminal patency.
His t-bili on discharge was 8.7. .
ID: The patient's white blood count and fever curves were closely watched for signs of infection.
Wound care was done daily, no signs or symptoms of infection were noticed.
Hematology: The patient's complete blood count was examined routinely; no transfusions were required.
His rehab facility was instructed to check daily weights, and check bilirubin levels every 2 days: the rehab facility was instructed to uncap his PTBD drain if the bilirubin levels begin to trend up.
)(s)* Refills:*2* 2. oxycodone 5 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for pain.
Discharge Instructions: You were admitted to Dr.[**Name (NI) 5067**] surgical service for evaluation and management of your duodenal perforation and biliary obstruction.
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 3000**], MD Phone:[**Telephone/Fax (1) 274**] Date/Time:[**2194-9-12**] 10:00 [**Hospital Ward Name 23**] 3, [**Hospital Ward Name **] .
